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Abstract
Charcot-Marie-Tooth disease (CMT) represents a group of neurodegenerative disorders typically characterised by
demyelination (CMT1) or distal axon degeneration (CMT2) of motor and sensory neurons. The majority of CMT2 cases
are caused by mutations in mitofusin 2 (MFN2); an essential gene encoding a protein responsible for fusion of the
mitochondrial outer membrane. The mechanism of action of MFN2 mutations is still not fully resolved. To investigate a role
for loss of Mfn2 function in disease we investigated an ENU-induced nonsense mutation in zebrafish MFN2 and
characterised the phenotype of these fish at the whole organism, pathological, and subcellular level. We show that unlike
mice, loss of MFN2 function in zebrafish leads to an adult onset, progressive phenotype with predominant symptoms of
motor dysfunction similar to CMT2. Mutant zebrafish show progressive loss of swimming associated with alterations at the
neuro-muscular junction. At the cellular level, we provide direct evidence that mitochondrial transport along axons is
perturbed in Mfn2 mutant zebrafish, suggesting that this is a key mechanism of disease in CMT. The progressive phenotype
and pathology suggest that zebrafish will be useful for further investigating the disease mechanism and potential treatment
of axonal forms of CMT. Our findings support the idea that MFN2 mutation status should be investigated in patients
presenting with early-onset recessively inherited axonal CMT.
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Introduction
Mitochondrial morphology depends on regulated fission and
fusion events. Mitofusin 2 (MFN2) mediates the fusion of
mitochondria, thus it is instrumental in this process [1]. There is
emerging evidence that disturbed mitochondrial dynamics con-
tributes to several human diseases, including major neurodegen-
erative disorders such as Parkinson’s disease [2,3]. Mutations in
MFN2 are known to be the leading cause of axonal Charcot-
Marie-Tooth disease (CMT), and are found in patients with CMT
type 2A and also in patients with hereditary motor and sensory
neuropathy type (HMSN) type VI [4,5]. The majority of MFN2
mutations are dominantly inherited, however their precise
mechanism of action remains controversial.
Gene targeting studies in mice suggest that MFN2 haploinsuffi-
ciency is not sufficient to cause a neurological phenotype [6]. On
the other hand, gain of function experiments in mice overexpress-
ing a CMT-linked mutant MFN2 allele, demonstrated that this
was sufficient to induce a specific neurological phenotype [7].
Despite this, several CMT patients with compound heterozygote
MFN2 mutations have been reported, and these all manifested as
recessively inherited CMT2A [8]. Thus it is feasible that mutant
MFN2 can cause CMT in both a dominant and a recessive
fashion, depending on the specific genetic defect. Complete loss of
function of MFN2 in gene-targeted mice results in a loss of
viability during early embryonic development, thus precluding
further investigation of juvenile and adult stages [6]. Recessive
MFN2 alleles have been identified as the cause of fetal-onset
axonal dystrophy in dogs [9] and fetal-onset neuroaxonal
dystrophy in Tyrolean cattle [10]. However in both these cases
the mutations were complicated; either a small deletion, or the
creation of a cryptic splice site. Therefore we chose to study loss of
MFN2 function in a complementary vertebrate model, the
zebrafish. Zebrafish are an excellent model organism for studying
neurological disorders. They have a well-conserved vertebrate
nervous system, and N-ethyl-N-nitrosourea (ENU) induced
mutations have so far been generated for approximately 31% of
all zebrafish genes (source: Zebrafish Mutation Project http://
www.sanger.ac.uk/Projects/D_rerio/zmp/). Furthermore for the
study of diseases affecting the nervous system, zebrafish motor and
sensory neurons closely resemble those in man, and diseases
including spinal muscular atrophy [11,12], hereditary spastic
paraplegia [12,13] and amyotrophic lateral sclerosis [14,15] have
been successfully modeled using zebrafish.
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We describe herein the characterisation of zebrafish bearing an
ENU-induced MFN2 nonsense mutation. These zebrafish develop
normally but subsequently manifest a progressive motor dysfunc-
tion and pathological alterations to the neuro-muscular junction
(NMJ), which are associated with defective axonal transport of
mitochondria. This vertebrate model supports a role for loss of
MFN2 function in the progressive motor dysfunction observed in
some CMT type 2A and HMSN type VI patients, and reinforce
the importance of evaluating MFN2 mutation state in recessive
cases of axonal CMT.
Materials and Methods
Zebrafish
All zebrafish were maintained in the University of Sheffield
aquaria at 28uC. All work with zebrafish was conducted in
accordance with UK law, under Project License 40/3323
‘‘Zebrafish models of neurodegenerative disease’’, granted to
AJG. This process includes review by the local ethical review panel
at the University of Sheffield. Mfn2 L285X fish (hu3528) were
generated in the Hubrecht Institute (Utrecht, Netherlands), and
were obtained from the Zebrafish Mutation Project at the Sanger
Centre, Hinxton, Cambridge UK. The L285X mutation generates
an additional restriction site for MseI, facilitating genotyping by
PCR followed by MseI digest. For survival experiments larvae
were raised in tanks containing 50 fish, and a mixture of
genotypes. After genotyping by fin-biopsy, fish were housed in
tanks containing only a single genotype.
Behavioral Assays
Swimming endurance was measured in the aquarium using a
custom-built swim tunnel apparatus based on one previously used
by the authors to characterise mutant SOD1 zebrafish [15].
Critical swimming speed (Ucrit) was calculated as previously
described [15,16,17]. Swimming posture was recorded by video
recording individually housed zebrafish in the aquarium. The
recordings were then scored by a blinded investigator, who
recorded the duration of any bouts of swimming at more than 30u
from horizontal.
In accordance with regulations relating to animal welfare we
closely monitored all zebrafish that showed signs of inability to
swim. Eventually mutant fish spent most of their time resting on
the floor of the tank. The humane endpoint for survival was taken
as the point at which these fish lost the ability to remain upright for
.50% of the observation time.
Immunostaining
NMJ staining was conducted as previously described [15].
Images were captured using an SP5 resonant scanning confocal
microscope (Leica, UK), and imported into ImageJ [18] for
analysis. Intensity correlation quotient (ICQ) [19] and pre- and
post-synaptic area were determined using the intensity correlation
analysis and particle analysis plugins for ImageJ.
Primary Neuronal Cultures
At 24 h after fertilisation zebrafish embryos were terminally
anaesthetized with tricaine (MS 222) and bleached according to
standard procedures [20]. Following bleaching the embryos were
dechorinated in sterile 80% Hanks Buffered Saline Solution
(Invitrogen), transferred to Ringer’s solution containing 0.25%
trypsin, and incubated at 28uC for 5 minutes. Embryos were then
triturated using fire-polished pasteur pipettes until a suspension of
single cells was obtained. Cells were suspended in media
containing 80% Lebovitz L15 (Invitrogen), 16 B27 supplement
(Invitrogen), 2% horse serum (Sigma), 5 mg/ml Pen/Strep,
10 ng/ml CNTF (R&D systems), 1 ng/ml BDNF (R&D systems),
and 100 pg/ml GDNF (R&D systems), and maintained on poly-L-
lysine coated 22622 mm glass coverslips at 28uC.
Live Imaging and Analysis
Zebrafish neurons were imaged and analysed as described
previously for mouse neurons [21,22], except the cultures were
maintained at 28uC.
Statistical Analysis
All analysis was performed using GraphPad Prism 6. Details of
specific tests are mentioned in the text and figure legends.
Results
A Zebrafish MFN2 Loss of Function Mutation
Human and zebrafish Mfn2 proteins share 82% amino acid
identity, and have a highly conserved GTPase domain, trans-
membrane domain and two heptad coiled coil domains
(Figure 1A). A T.A mutation in exon 8 of zebrafish MFN2 was
identified in the Zebrafish Mutation Project. This mutation
introduces a novel MseI restriction enzyme site allowing genotyp-
ing by PCR and MseI enzyme digest (Figure 1B). The mutation
leads to the introduction of a stop codon at leucine 285
(MFN2L285X), which truncates the protein after the GTPase
domain thus removing the transmembrane domain essential for
mitochondrial fusion, and therefore produces an Mfn2 protein
that is predicted to be non-functional (Figure 1A). Despite the high
level of homology, commercial antibodies raised against human
Mfn2 failed to recognise the zebrafish protein. Mfn2 plays an
important role in mitochondrial fusion events [6]; furthermore we
were unable to find evidence for nonsense mediated decay of the
mutant mRNA using RT-PCR (data not shown). Therefore in
order to seek direct evidence for loss of Mfn2 function we
investigated the elongated morphology of mitochondria in the
axons of MFN2 mutant zebrafish. To achieve this we derived
primary neuronal cultures from 24h MFN2+/+, MFN2L285X/+,
and MFN2L285X/L285X zebrafish embryos, and stained and
imaged mitochondria at 7DIV using Mitotracker Red. Morphol-
ogy was quantified by calculating the aspect ratio, a measure of
overall mitochondrial shape calculated by dividing the major axis
of a bounding ellipse by the minor axis [23]. The aspect ratio in
homozygous mutant neurons was (1.7560.54), significantly
reduced compared to mitochondria in wild type neurons
Figure 1. A zebrafish MFN2 mutant. (A) CLUSTAL alignment of zebrafish (Danio rerio: DR) and human (Homo sapiens: HS) Mfn2 protein
sequences (Ensembl). The solid and dashed lines indicate the GTPase and transmembrane domains respectively. The site of the ENU induced point
mutation (L285) is indicated with an arrowhead. (B) The ENU induced mutation creates a novel restriction enzyme site for MseI, allowing genotyping
using PCR followed by MseI digest. The agarose gel shows, from left to right: Hyperladder V (Bioline), two wild type embryos (MFN2+/+), two mutation
carriers (MFN2L285X/+), and two homozygotes (MFN2L285X/L285X). (C) Mitochondria in cultured MFN2L285X/L285X neurons have a significantly reduced
aspect ratio (p,0.01, Kruskal-Wallis with Dunn’s multiple comparisons test). (D) Representative images of axonal mitochondria stained with
Mitotracker Red in cultured neurons of the indicated genotypes.
doi:10.1371/journal.pone.0067276.g001
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Figure 2. Characterisation of the phenotype of adult MFN2L285X mutant zebrafish. (A) Survival curve showing loss of viability of MFN2L285X/
L285X zebrafish from 170 days onwards (p,0.0001, Log-rank (Mantel-Cox) test). (B) Bar graph of body weight for all three groups of siblings at 60–70
days old (p,0.0001, Kruskal-Wallis with Dunn’s multiple comparisons test). (C) Bar graph of the nose to tail length of MFN2L285X mutant and sibling
zebrafish at 60–70 days old (p,0.001, Kruskal-Wallis with Dunn’s multiple comparisons test).
doi:10.1371/journal.pone.0067276.g002
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(2.1260.91) (Figure 1C–D). This result implies that the
MFN2L285X mutation behaves as a true loss of function null allele
in the zebrafish model, leading to altered mitochondrial dynamics
and a change in mitochondrial morphology.
Characterisation of MFN2 Mutant Zebrafish
MFN2 null mutation leads to early embryonic lethality in mouse
due to placental defects [6]. Zebrafish embryos are nourished by a
yolk sac and thus have no requirement for a placenta. To explore
the possibility that zebrafish MFN2 null mutants will develop
normally we studied the progeny of in-crosses between
MFN2L285X/+ fish. Embryonic MFN2L285X/L258X zebrafish were
viable, and both CNS development and swimming behavior was
indistinguishable from siblings (data not shown). Since CMT2A
patients show disease onset in early or mid-life we carried out an
additional MFN2L285X/+ in-cross, and closely monitored survival
and the phenotype of the offspring (n = 230). There was no
difference in survival amongst young adults, all three genotypes
showing approximately 85% survival at the time of fin biopsy for
genotyping (60–70 days old; Figure 2A). We noticed that
MFN2L285X/L258X mutants appeared somewhat smaller their
siblings. To test this we recorded the length and weight of all
fish prior to fin biopsy. By comparing the length and weight of fish
grouped by genotype it was clear that MFN2L285X/L285X fish were
significantly smaller that their wild type and heterozygous siblings
(Figure 2C–D). We also determined the overall viability of MFN2
mutant zebrafish, and this revealed a gradual decline in survival of
MFN2L285X/L258X mutants from 175 days onwards (p,0.0001
Mantel-Cox log-rank test; Figure 2A).
MFN2 Mutation Leads to Progressive Loss of Motor
Function
To determine whether loss of Mfn2 function could lead to
motor defects such as those reported in CMT2A we investigated
swimming behavior as a read-out of motor function. Close
observation of adult MFN2L285X/L285X zebrafish suggested that
they displayed altered swimming posture compared to their
siblings. Thus we used an established method to determine the
critical swimming velocity (Ucrit) of MFN2+/+, MFN2L285X/+, and
MFN2L285X/L285X zebrafish at 100 and 200 days [15,24]. We
deployed a swim tunnel apparatus identical to that described
previously [15] to determine the maximum flow rate which fish
could swim against for a sustained period. This test is similar in
nature to the rotarod test used to measure motor dysfunction in
mouse models. The results demonstrate that adult MFN2L285X/
L285X zebrafish show a progressive loss of endurance swimming
between 100 and 200 days old (Figure 3A). In keeping with this the
Ucrit in 100 and 200 day-old MFN2+/+ and MFN2L285X/+
zebrafish was 28 cm/s, which was significantly reduced to
12.1167.55 cm/s (mean 6 S.D) (p,0.01, Kruskal-Wallis test) in
100 day-old and 4.5563.23 cm/s (p,0.001) in 200 day-old
MFN2L285X/L285X zebrafish.
Freely swimming zebrafish normally maintain a horizontal
posture except when swimming to the top or the bottom of the
tank. By video recording a side-view of MFN2+/+ zebrafish freely
swimming in a fish tank we determined the typical swimming
angle of adult zebrafish per minute of observation (Figure 3B). The
frequency distribution for swimming angle measured between the
head and the tail of MFN2+/+ fish is Gaussian. MFN2+/+ zebrafish
spend less than 5% of the time swimming at an angle greater than
30u below horizontal. MFN2L285X/L258X zebrafish were unable to
maintain a horizontal posture, and frequently their tail dropped
such that they assumed an angled posture (Figure 3B). Post
mortem analysis excluded the possibility that this was caused by
defective swim bladder inflation. We hypothesised that this altered
swimming posture was another outcome of motor impairment in
the MFN2L285X/L258X zebrafish, and therefore made video
recordings of a cohort of 90 day-old MFN2+/+ and MFN2L285X/
L285X zebrafish swimming in individual tanks, and then calculated
the proportion of time spent swimming normally i.e. at an angle of
less than 30u from horizontal (Figure 3C). We also determined the
average duration of bouts of abnormal posture, swimming at more
than 30u from horizontal (Figure 3D). MFN2L285X/L285X zebrafish
exhibited significant alterations in both these parameters, thus we
investigated whether the changes in motor performance were
progressive by investigating all 3 groups of MFN2+/+,
MFN2L285X/+, and MFN2L285X/L285X zebrafish at 105, 130 and
155 days old (Figures 3E-3F). Only MFN2L285X/L285X zebrafish
showed a progressive decline in the percentage of time spent
swimming normally (Figure 3E). They also showed an increase in
the duration of bouts of abnormal swimming, demonstrating the
progressive nature of motor dysfunction in these zebrafish
(Figure 3F). Therefore we conclude that loss of Mfn2 function is
associated with progressive motor defects in adult zebrafish.
Loss of Motor Function is Associated Aberrant NMJ
Pathology
Distal axonopathy is a clinical feature of CMT. To determine
whether the altered swimming in MFN2 mutant zebrafish was
associated with defects in the distal axon we investigated NMJ
pathology in non-symptomatic (15 day-old larvae) and symptom-
atic (200 day-old adult) zebrafish. Using SV2 as a presynaptic
marker that labels motor neurons, and a-bungarotoxin a post-
synaptic marker of the NMJ, we used whole mount immunoflu-
orescent staining and confocal microscopy to quantify the intensity
correlation quotient (ICQ) [19] and size of pre- and post-synaptic
compartments in the trunk musculature. The ICQ is a statistically
testable single-value assessment of the relationship between two
staining patterns: colocalising signals have 0,ICQ#+0.5, for
random staining ICQ=0, and for non-colocalising (segregated)
staining 0.ICQ$–0.5 [19]. In 15 day-old mutant zebrafish
(Figure 4A) SV2 and a-bungarotoxin showed ICQ values of
0.23760.054, similar to that of controls (Figure 4B), and the pre-
and post-synaptic areas (Figure 4C–4D) were also similar in
mutants and controls. We found that adult NMJs show increases in
both the ICQ and pre/post synaptic area compared to larvae. At
Figure 3. MFN2L285X/L285X zebrafish have a progressive swimming defect. (A) Kaplan-Meier plot of swimming endurance in 100 and 200
day-old zebrafish of each genotype. MFN2+/+ and MFN2L285X/+ zebrafish swam for 30 minutes at both 100 and 200d old. For clarity only the 200d
data is plotted, although the lines are superimposed. (MFN2L285X/L285X: p,0.001 at both ages, Log-rank (Mantel-Cox) test). (B) Frequency distribution
plot of swimming angle (measured from horizontal) of adult wild type zebrafish. Representative frames captured from digital video recordings of
adult zebrafish and cartoons are shown. The upper panel shows a wild type sibling, and the lower panel shows a MFN2L285X/L285X zebrafish showing
abnormal posture, with the body angled at 30u from horizontal. (C) Bar graph showing the percentage of time spent with normal swimming posture
during 1 minute of observation in 90 day-old zebrafish (p,0.0001, 2-sided T test Mann-Whitney). (D) Bar graph showing the mean duration of each
bout of abnormal swimming in 90 day-old old zebrafish (p,0.0001, 2-sided T test Mann-Whitney). (E, F) Graphs showing the decline in normal
swimming posture (E) and the increasing duration of each bout of abnormal swimming (F), between 105 and 155 days old.
doi:10.1371/journal.pone.0067276.g003
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Figure 4. Alterations of NMJ pathology in MFN2L285X larvae (A–D) and adults (E–H). (A) Representative images of dual
immunofluorescence staining of whole mount 15d larvae of each genotype for a-Bungarotoxin (green) and SV2 (red). (B) ICQ analysis of 3 larvae
per group reveals no alteration of SV2/a-Bungarotoxin co-localisation in MFN2L285X/+ or MFN2L285X/L285X larvae. Compared to siblings the (C) pre-
synaptic area, and (D) post-synaptic area are not significantly different in MFN2L285X/+ or MFN2L285X/L285X larvae. (E) Representative images of a-
Bungarotoxin (green) and SV2 (red) in 200 day-old zebrafish. (F) ICQ is significantly reduced in MFN2L285X/L285X at this stage, and there are significant
reductions in the pre- and post-synaptic area (G and H). Scale bars = 10 mm.
doi:10.1371/journal.pone.0067276.g004
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Figure 5. Analysis of axonal transport of mitochondria. (A) Representative kymographs showing defective axonal transport of mitochondria
along axons of cultured zebrafish neurons from MFN2L285X/L285X embryos compared with MFN2+/+ and MFN2L285X/+ neurons. (B) Mitochondria in
cultured MFN2L285X/L285X neurons are significantly less motile; anterograde displacement of mitochondria is not significantly altered, but retrograde
displacement is significantly reduced (p,0.01, one-way ANOVA). (C) The velocity of retrograde but not anterograde mitochondrial transport is
significantly reduced in cultured MFN2L285X/L285X neurons (p,0.001, Kruskal-Wallis with Dunn’s multiple comparisons test). (D) Representative images
of axons from neurons of each genotype. The cell body is to the left, and distal axon is to the right hand side (scale bar = 10 mm) (E) Comparison of
mitochondrial density in proximal and distal axonal segments, there is a significant reduction in mitochondrial density in the proximal but not distal
segment of MFN2L285X/L285X neurons (p,0.05, 2-way ANOVA with Bonferroni’s multiple comparisons test). (F) There is a significant increase in the
inter-mitochondrial distance in the proximal axon of MFN2L285X/L285X neurons (p,0.01, 2-way ANOVA with Bonferroni’s multiple comparisons test).
doi:10.1371/journal.pone.0067276.g005
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200 days (Figure 4E), when the fish displayed clear alterations in
swimming, ICQ was significantly reduced in homozygous mutants
compared with controls (0.37260.043 in mutants and
0.42760.025 in controls) (Figure 4F) and the area of both pre-
and post-synaptic compartments (Figure 4G–4H) was also
significantly reduced (p,0.01 one-way ANOVA with Bonferoni’s
multiple comparison test). Therefore we conclude that altered
swimming in Mfn2 zebrafish is associated with defects at the NMJ.
Axonal Transport of Mitochondria is Defective in
Homozygous MFN2 Mutant Neurons
CMT type 2A affects the distal axons of motor, and to a lesser
extent, sensory neurons, which are the longest cells in the human
body. We have previously showed that changes in mitochondrial
morphology are associated with altered mitochondrial transport
[21,23]. Furthermore loss of MFN2 function in mouse neurons
leads to changes in axonal transport of mitochondria [25,26].
Thus it is possible that MFN2 loss of function in the zebrafish
model leads to impaired NMJ pathology and loss of motor
function by a mechanism involving disruption of mitochondrial
transport along axons. Therefore we used time-lapse imaging of
Mitotracker red-labeled mitochondria to quantify mitochondrial
transport in cultured neurons obtained from MFN2L285X zebrafish
and control siblings. Representative kymographs of mitochondrial
transport are shown in Figure 5A. These reveal evidence for a
reduction in retrograde transport in the MFN2L285X/L285X
neurons. By analyzing time-lapse recordings we confirmed that
the number of motile mitochondria is significantly reduced in
MFN2L285X/L285X neurons (Figure 5B). This is similar to the
reduced mobility of mitochondria reported in dorsal root ganglion
neurons derived from MFN2 knockout mice [27]. We investigated
the possibility of differential effects on anterograde and retrograde
transport of mitochondria, and found that retrograde transport
was selectively impaired in MFN2L285X/L285X neurons (P,0.05)
(Figure 5B). To understand the basis for this we measured the
velocity of mitochondrial transport (Figure 5C), and discovered a
significant reduction in the velocity of mitochondria being
transported in the retrograde direction. Thus we find evidence
for a selective impairment of retrograde mitochondrial transport in
the zebrafish model. To determine whether defective axonal
transport of mitochondria could be due to degeneration of axons
in this model, we investigated the average length of axons in the
primary neuron cultures. There were no significant differences in
axonal length in any of the cultures (data not shown) suggesting
that the mitochondrial transport defects are not arising because of
underlying axon degeneration.
MFN2 Mutation Leads to Altered Mitochondrial
Distribution Along Axons
Alterations in mitochondrial transport are predicted to disturb
the normal distribution of mitochondria along the axon, as we
have previously reported in models of amyotrophic lateral sclerosis
and hereditary spastic paraplegia [21,22]. This defect could
underlie axonal dysfunction and the progression of symptoms. In
keeping with defective mitochondrial transport in CMT2A,
muscle biopsies from patients have revealed an irregular distribu-
tion of mitochondria in axons [28]. To investigate whether axonal
transport defects cause a similar effect in the zebrafish model we
imaged axons from cultured zebrafish neurons, which suggested a
change in mitochondrial distribution in the proximal segment of
MFN2L285X/L285X neurons (Figure 5D). We therefore analysed the
mean mitochondrial density (number of mitochondria per micron
of axon), and inter-mitochondrial distance, in proximal and distal
axonal segments. This revealed a significant reduction in
mitochondrial density and an increase in inter-mitochondrial
distance in the proximal, but not the distal, axon (Figure 5D–5E).
These results suggest that MFN2L285X specifically affects retro-
grade transport leading to altered distribution of mitochondria
along the axon, consistent with previous observations in CMT2A
patient sural nerve biopsies [28].
Discussion
The zebrafish MFN2 mutant we report here provides important
new data relating to the pathogenesis of CMT2A. The majority of
MFN2 mutations reported in CMT are inherited in an autosomal
dominant fashion [28], however autosomal recessive inheritance
has recently been reported in three different families [8].
Autosomal dominant CMT2A has been faithfully modeled by
expressing a mutant MFN2 allele in mouse [29]. However to date,
MFN2 null models have resulted in early embryonic defects in
mice due to aberrant placental development [6], and investigation
of MFN2 loss of function in mice has relied on cell specific gene
silencing [25,30]. These studies have provided clear evidence for
the importance of MFN2 in Purkinje cells and striatal neurons. If
these cell types are affected in CMT patients, then it is at a sub-
clinical level. Thus the role of MFN2 null alleles is still not
properly understood at the level of the whole organism, which is
particularly relevant to better understand the rare recessive MFN2
alleles. We describe a zebrafish MFN2 null allele that causes a
progressive loss of motor function that is inherited in an autosomal
recessive fashion. In contrast to embryos injected with morpholino
oligonucleotides targeting a splice site in MFN2, which show early
developmental defects [31], the stable MFN2L285X zebrafish
appear healthy as embryos. This is likely to be accounted for by
maternal inheritance of MFN2 mRNA and protein in the mutants.
We were unable to address this further since homozygous MFN2
mutants were not able to breed successfully. Alternatively Mfn1
function may compensate for Mfn2 defects during embryogenesis.
Genomic analysis suggests that zebrafish have two loci encoding
orthologues of MFN1. The observation that MFN2L285X/L285X
zebrafish are smaller than their siblings is interesting because
mutant tardbp zebrafish are also smaller at this stage of
development [32]. These findings have implications for husbandry
of zebrafish mutants bearing mutations in human neurological
disease genes.
Our zebrafish model provides support for loss of MFN2
function in axonal CMT, in particular it is consistent with the
idea that the recessive forms of axonal CMT with compound
heterozygote MFN2 mutations [8], are caused by substantially
reduced, or complete loss of Mfn2 function. Because of the
existence of dominant and recessively inherited mutations in
MFN2, it now seems possible that MFN2 leads to CMT through
both gain and loss of function mechanisms. This idea is supported
by evidence for disrupted mitochondrial transport in the
MFN2L285X/L285X zebrafish, which was also reported in embry-
onic neurons cultured from the mouse MFN2 knock-out, and the
mouse transgenic gain of function model [7,25].
Since the principal target of the L285X mutation is mitochon-
dria we investigated mitochondrial transport in this model.
Quantitative analysis of mitochondrial motility revealed significant
reductions in both the frequency and velocity of retrograde
mitochondrial movements. It has previously been shown in mouse
that Mfn2 interacts with Miro and that silencing of Miro replicates
the effect of Mfn2 knockout on axonal transport [27]. Miro is
known to interact with anterograde (kinesin) motors, however the
relationship between anterograde and retrograde motors and the
Axonal Transport in a Zebrafish Model of CMT
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net rate of transport is complex, thus it is possible that disruption
of Mfn2/Miro in the L285X zebrafish model contributes to the
observed retrograde transport defects.
The MFN2L285X model offers an opportunity for further
research into recessive CMT associated with compound hetero-
zygote MFN2 mutation. Zebrafish models are proving to be useful
for identifying novel therapeutic approaches, either by directly
testing candidate drugs [33], or by leveraging the power of genetic
screens to identify novel disease modifier genes [34], which will
lead to new avenues of therapy development.
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